Intraocular Mantle Cell Lymphoma of the Iris

被引:9
|
作者
Reid, Jonathan P. [1 ]
Puglis, Christie L. [2 ]
Slagle, William Scott [1 ,3 ]
机构
[1] Salem Vet Affairs Med Ctr, Salem, VA USA
[2] Wing Eyecare, Cincinnati, OH USA
[3] Virginia Tech Carilion Sch Med, Roanoke, VA USA
关键词
mantle cell lymphoma; non-Hodgkin lymphoma; uveitis; anisocoria; mutton-fat keratic precipitates; DIAGNOSIS; MASS;
D O I
10.1097/OPX.0000000000000218
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose Non-Hodgkin lymphoma (NHL) is a neoplastic process of the lymphatic system in which tumors develop from lymphocytes. The absence of Reed-Sternberg cells differentiates NHL from Hodgkin lymphoma (HL). Mantle cell lymphoma is a mature B-cell NHL, typically with an aggressive course. Manifestations of intraocular mantle cell lymphoma include anterior uveitis, morphologic changes to the uvea, vitritis, intraocular masses, as well as subretinal or choroidal infiltrates. Case Report A 71-year-old white man with known mantle cell lymphoma presents with recent-onset blurred vision in the left eye resulting from an atypical anterior chamber cellular reaction. Iris examination reveals topographic and morphologic atypia suggestive of neoplasia. He subsequently developed posterior cervical lymph node involvement indicating recurrence of his mantle cell lymphoma. He was restarted on chemotherapy and radiation. The iris and anterior chamber reaction responded to systemic oncological therapy. Conclusions Mantle cell lymphoma may present with ocular manifestations such as an anterior chamber cellular reaction and morphologic changes to the uvea. This case stresses the importance of seeking an etiology in any secondary or atypical uveitis.
引用
收藏
页码:S25 / S29
页数:5
相关论文
共 50 条
  • [41] Management of mantle cell lymphoma
    P. Meusers
    J. Hense
    Annals of Hematology, 1999, 78 : 485 - 494
  • [42] Update on mantle cell lymphoma
    Maddocks, Kami
    BLOOD, 2018, 132 (16) : 1647 - 1656
  • [43] The Kinetics of mantle cell lymphoma
    Craig, FE
    Siebert, JD
    Grogan, TM
    Banks, PM
    LABORATORY INVESTIGATION, 1996, 74 (01) : 637 - 637
  • [44] Mantle cell lymphoma.
    Densmore J.J.
    Williams M.E.
    Current Treatment Options in Oncology, 2000, 1 (3) : 281 - 285
  • [45] Management of mantle cell lymphoma
    Armitage, JO
    ONCOLOGY-NEW YORK, 1998, 12 (10): : 49 - 55
  • [46] MANTLE-CELL LYMPHOMA
    DEWOLFPEETERS, C
    PITTALUGA, S
    ANNALS OF ONCOLOGY, 1994, 5 : S35 - S37
  • [47] Hidden mantle cell lymphoma
    Lakic, T.
    Sunjevic, M.
    Ilic, A.
    Lovrenski, A.
    Krajnovic, B.
    Panjkovic, M.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S273 - S273
  • [48] Mantle-cell lymphoma
    Campo, E
    Raffeld, M
    Jaffe, ES
    SEMINARS IN HEMATOLOGY, 1999, 36 (02) : 115 - 127
  • [49] Mantle-cell lymphoma
    Sun, WM
    Chotiprasidhi, P
    Finn, W
    GASTROINTESTINAL ENDOSCOPY, 2005, 61 (07) : 875 - 875
  • [50] Therapy of mantle cell lymphoma
    Dreyling, M.
    Unterhalt, M.
    Weigert, O.
    Hiddemann, W.
    INTERNIST, 2007, 48 (04): : 382 - 388